mhurhangee/patent-ind-claim-en huggingface dataset:
A communication method, wherein the method is applicable to a wireless communication system, the wireless communication system comprises a first cell, the first cell comprises a plurality of terminal devices that can transmit uplink data on a same uplink time-frequency resource, the plurality of terminal devices comprise a first terminal device, and the method comprises: determining (S501), by the first terminal device, a reference time domain location based on a preconfigured uplink time-frequency resource, wherein the reference time domain location is the same as a reference time domain location determined by another terminal device in the plurality of terminal devices; determining (S502), by the first terminal device, a time domain location that is (first duration x N + second duration x (N - 1)) away from the reference time domain location as a start time domain location of X gaps of the second duration, wherein N is 1, 2, 3, 4, ..., X, none of the X gaps is used to send uplink data, the first duration and the second duration are positive numbers, and X is a positive integer; determining (S503), by the first terminal device, a time domain location that is (first duration x (M - 1) + second duration x (M - 1)) away from the reference time domain location as a start time domain location of Y first durations, wherein all or a part of a time domain resource corresponding to at least one of the Y first durations is a time domain resource in a first time-frequency resource used to transmit the uplink data, M is 1, 2, 3, 4, ..., Y, and Y = X or Y = X + 1; and sending (S507), by the first terminal device, uplink data to a network device on the first time-frequency resource. determining (S501), by the first terminal device, a reference time domain location based on a preconfigured uplink time-frequency resource, wherein the reference time domain location is the same as a reference time domain location determined by another terminal device in the plurality of terminal devices; determining (S502), by the first terminal device, a time domain location that is (first duration x N + second duration x (N - 1)) away from the reference time domain location as a start time domain location of X gaps of the second duration, wherein N is 1, 2, 3, 4, ..., X, none of the X gaps is used to send uplink data, the first duration and the second duration are positive numbers, and X is a positive integer; determining (S503), by the first terminal device, a time domain location that is (first duration x (M - 1) + second duration x (M - 1)) away from the reference time domain location as a start time domain location of Y first durations, wherein all or a part of a time domain resource corresponding to at least one of the Y first durations is a time domain resource in a first time-frequency resource used to transmit the uplink data, M is 1, 2, 3, 4, ..., Y, and Y = X or Y = X + 1; and sending (S507), by the first terminal device, uplink data to a network device on the first time-frequency resource.
A method of detecting the presence of Neisseria gonorrhoeae in a sample, comprising a step of detecting a target sequence of NG01642 or a fragment thereof, wherein the target sequence or the the fragment thereof comprises at least 10 contiguous nucleotides contained in SEQ ID NO: 1 or its complement; at least 10 nucleotides contained in SEQ ID NO: 25 or its complement; or at least 10 nucleotides contained in SEQ ID NO: 2 or its complement, wherein optionally the target sequence comprises at least 30 contiguous nucleotides contained in SEQ ID NO: 25 or SEQ ID NO: 2.
A capsulated self-emulsifying preparation having a self-emulsifying composition comprising, when the self-emulsifying composition is defined to be 100% by weight as a whole, a) 70 to 90% by weight of ethyl eicosapentaenoate, b) 0.5 to 6% by weight of water, and c) 1 to 29% by weight of an emulsifying agent including either i) a polyoxyethylene sorbitan fatty acid ester or ii) at least two members selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, or 1 to 29% by weight of an emulsifying agent including i) a polyoxyethylene sorbitan fatty acid ester and ii) at least one member selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, wherein d) content of ethanol is up to 4% by weight of the whole composition, and e) content of polyhydric alcohol is up to 4% by weight of the whole composition, said self-emulsifying composition being held in a capsule as a liquid content, wherein the capsule is a hard capsule and/or a soft capsule. a) 70 to 90% by weight of ethyl eicosapentaenoate, b) 0.5 to 6% by weight of water, and c) 1 to 29% by weight of an emulsifying agent including either i) a polyoxyethylene sorbitan fatty acid ester or ii) at least two members selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, or 1 to 29% by weight of an emulsifying agent including i) a polyoxyethylene sorbitan fatty acid ester and ii) at least one member selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, wherein i) a polyoxyethylene sorbitan fatty acid ester or ii) at least two members selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, or i) a polyoxyethylene sorbitan fatty acid ester and ii) at least one member selected from the group consisting of a sorbitan fatty acid ester, a glycerin fatty acid ester and a polyoxyethylene castor oil, wherein d) content of ethanol is up to 4% by weight of the whole composition, and e) content of polyhydric alcohol is up to 4% by weight of the whole composition,
A method of producing propanol and/or propionic acid, the method comprising: (b) contacting at least one propionogen with carbon dioxide and with an aqueous medium comprising ethanol and acetate; wherein the acetate is maintained at a concentration of at least 1 g/L in the aqueous medium during the reaction period.
A lithographic printing plate precursor comprising: an image-recording layer on a hydrophilic support, wherein the image-recording layer includes a polymer particle including an addition polymerization-type resin having a hydrophilic structure and a crosslinking structure, an infrared absorber, a polymerization initiator, a polymerizable compound, and a radical production aid, wherein the polymerization initiator is an onium salt, and characterized in that the radical production aid is a borate compound, and that the crosslinking structure includes at least one constituent unit selected from the group consisting of constituent units represented by BR-1 to BR-16, in the structure, R BR each independently represent a hydrogen atom or a methyl group, and n represents an integer of 1 to 20. an image-recording layer on a hydrophilic support, wherein the image-recording layer includes a polymer particle including an addition polymerization-type resin having a hydrophilic structure and a crosslinking structure, an infrared absorber, a polymerization initiator, a polymerizable compound, and a radical production aid, wherein the polymerization initiator is an onium salt, and characterized in that the radical production aid is a borate compound, and that the crosslinking structure includes at least one constituent unit selected from the group consisting of constituent units represented by BR-1 to BR-16, in the structure, R BR each independently represent a hydrogen atom or a methyl group, and n represents an integer of 1 to 20.
A vehicle control station comprising: a first hand rest ; at least one first micro-joystick positioned relative to the first hand rest such that the first hand rest is configured to locate an operator's hand and fingers in position to operate the at least one first micro-joystick; and a first function enable switch configured to activate the at least one first micro-joystick, characterised in that the first function enable switch is positioned relative to the first hand rest for operation by one of the operator's fingers different from those positioned to operate the at least one first micro-joystick, and wherein the first function enable switch is positioned relative to the first hand rest for operation by a thumb of the operator. a first hand rest ; at least one first micro-joystick positioned relative to the first hand rest such that the first hand rest is configured to locate an operator's hand and fingers in position to operate the at least one first micro-joystick; and a first function enable switch configured to activate the at least one first micro-joystick, characterised in that the first function enable switch is positioned relative to the first hand rest for operation by one of the operator's fingers different from those positioned to operate the at least one first micro-joystick, and wherein the first function enable switch is positioned relative to the first hand rest for operation by a thumb of the operator.
A usage measuring device for measuring usage of a gear transmission , comprising: an oscillation- cycle measuring unit configured to measure the time-period of an oscillation cycle of a residual signal indicating at least one of a rotational state of an input unit side and a rotational state of an output unit side of the gear transmission ; and a comparing unit configured to compare a length of a first oscillation cycle measured during an initial operating period of the gear transmission to a second oscillation cycle time-period measured after the gear transmission has operated for a predetermined time, wherein the oscillation cycle measuring unit is configured to measure the first oscillation cycle time-period and the second oscillation cycle time-period of the residual signal immediately after the gear transmission has stopped driving but the residual signal continues to occur for a short time. an oscillation- cycle measuring unit configured to measure the time-period of an oscillation cycle of a residual signal indicating at least one of a rotational state of an input unit side and a rotational state of an output unit side of the gear transmission ; and a comparing unit configured to compare a length of a first oscillation cycle measured during an initial operating period of the gear transmission to a second oscillation cycle time-period measured after the gear transmission has operated for a predetermined time, wherein the oscillation cycle measuring unit is configured to measure the first oscillation cycle time-period and the second oscillation cycle time-period of the residual signal immediately after the gear transmission has stopped driving but the residual signal continues to occur for a short time.
The use of an enzyme having cellulase activity in a consumer product composition, and more particularly a fabric conditioner composition or a scent booster composition for improving deposition of a fragrance onto a textile.
A microorganism of the Bacillus sp. BIRD-6 strain with accession number CECT 9748.
A media holder for use with a media processor, the media holder comprising: a spool comprising: a winding drum defining an axis and a first diameter, a flange defining a second diameter that is larger than the first diameter; an antenna located on the flange, wherein the antenna comprises at least one arcuate conductor concentric with the axis of the winding drum; and a memory located on the flange and disposed in communication with the antenna, the memory configured to store an identification number and an authentication number; wherein the authentication number is at least partially an encrypted transformation of the identification number. a spool comprising: a winding drum defining an axis and a first diameter, a flange defining a second diameter that is larger than the first diameter; a winding drum defining an axis and a first diameter, a flange defining a second diameter that is larger than the first diameter; an antenna located on the flange, wherein the antenna comprises at least one arcuate conductor concentric with the axis of the winding drum; and a memory located on the flange and disposed in communication with the antenna, the memory configured to store an identification number and an authentication number; wherein the authentication number is at least partially an encrypted transformation of the identification number.
A personal care composition comprising: a. glutathione precursor comprising, by weight of the composition: i. from about 0.001% to about 2% of cystine; ii. optionally, from about 0.01 to about 10% of glycine; iii. from about 0.01 to about 10% of a glutamate source selected from the group consisting of glutamine, glutamine ester, glutamic acid, pyroglutamic acid, salts, and mixtures thereof; and iv. from about 0.001 to about 3% of a resorcinol of Formula I: wherein R is an ethyl group optionally substituted with a phenyl or substituted phenyl group or C3 to C16 straight or branched alkyl group optionally substituted with a phenyl or substituted phenyl group; and b. a cosmetically acceptable carrier; c. wherein the pH of the composition is in the range of from about 3.5 to about 8.5. a. glutathione precursor comprising, by weight of the composition: i. from about 0.001% to about 2% of cystine; ii. optionally, from about 0.01 to about 10% of glycine; iii. from about 0.01 to about 10% of a glutamate source selected from the group consisting of glutamine, glutamine ester, glutamic acid, pyroglutamic acid, salts, and mixtures thereof; and iv. from about 0.001 to about 3% of a resorcinol of Formula I: wherein R is an ethyl group optionally substituted with a phenyl or substituted phenyl group or C3 to C16 straight or branched alkyl group optionally substituted with a phenyl or substituted phenyl group; and i. from about 0.001% to about 2% of cystine; ii. optionally, from about 0.01 to about 10% of glycine; iii. from about 0.01 to about 10% of a glutamate source selected from the group consisting of glutamine, glutamine ester, glutamic acid, pyroglutamic acid, salts, and mixtures thereof; and iv. from about 0.001 to about 3% of a resorcinol of Formula I: wherein R is an ethyl group optionally substituted with a phenyl or substituted phenyl group or C3 to C16 straight or branched alkyl group optionally substituted with a phenyl or substituted phenyl group; and b. a cosmetically acceptable carrier; c. wherein the pH of the composition is in the range of from about 3.5 to about 8.5.
An electric vehicle comprising: a board including first and second deck portions each configured to receive a left or right foot of a rider oriented generally perpendicular to a longitudinal axis (A2) of the board; a wheel assembly including a ground-contacting element disposed between and extending above the first and second deck portions; a motor assembly mounted to the board and configured to rotate the ground-contacting element around an axle to propel the electric vehicle; at least one orientation sensor configured to measure orientation information of the board; a first sensing region disposed in the first deck portion, the first sensing region including two pressure-sensing transducers spaced apart from each other, such that a first of the two pressure-sensing transducers registers with a first portion of a foot of the rider and a second of the two pressure-sensing transducers registers with a second portion of the same foot of the rider; and a motor controller configured to receive board orientation information measured by the orientation sensor and rider presence information based on outputs of the two pressure-sensing transducers, and to cause the motor assembly to propel the electric vehicle based on the board orientation information and the rider presence information; wherein the motor controller is further configured to halt the motor assembly in response to activation of exactly zero or exactly one of the two pressure-sensing transducers when a speed of the electric vehicle is below a threshold value. a board including first and second deck portions each configured to receive a left or right foot of a rider oriented generally perpendicular to a longitudinal axis (A2) of the board; a wheel assembly including a ground-contacting element disposed between and extending above the first and second deck portions; a motor assembly mounted to the board and configured to rotate the ground-contacting element around an axle to propel the electric vehicle; at least one orientation sensor configured to measure orientation information of the board; a first sensing region disposed in the first deck portion, the first sensing region including two pressure-sensing transducers spaced apart from each other, such that a first of the two pressure-sensing transducers registers with a first portion of a foot of the rider and a second of the two pressure-sensing transducers registers with a second portion of the same foot of the rider; and a motor controller configured to receive board orientation information measured by the orientation sensor and rider presence information based on outputs of the two pressure-sensing transducers, and to cause the motor assembly to propel the electric vehicle based on the board orientation information and the rider presence information; wherein the motor controller is further configured to halt the motor assembly in response to activation of exactly zero or exactly one of the two pressure-sensing transducers when a speed of the electric vehicle is below a threshold value.
Cosmetic use of a composition comprising a peptide of formula (I), R 1 -(AA) n -Ala-Val-Leu-Ala-Gly-(AA) p -R 2 (I) wherein AA represents any amino acid or one of its derivatives, and n and p are integers between 0 and 4; R 1 represents the primary amine function of the N-terminal amino acid, free or substituted by a protector group which can be selected from acetyl, benzyl, tosyl and benzyloxycarbonyl; R 2 represents the hydroxyl function of the carboxyl acid of C-terminal amino acid, free or substituted by a protector group which can be selected from C 1 to C 30 alkyl, -NH 2 , -NHY and -NYY group with Y representing a C 1 to C 4 alkyl, for increasing the expression of Ubiad1 in skin, skin appendages or epidermal cells including keratinocytes for improving physiological functions of the skin, comprising contacting the skin, skin appendages or epidermal cells with a composition containing the peptide, wherein the peptide of formula (I) consists of the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2. AA represents any amino acid or one of its derivatives, and n and p are integers between 0 and 4; R 1 represents the primary amine function of the N-terminal amino acid, free or substituted by a protector group which can be selected from acetyl, benzyl, tosyl and benzyloxycarbonyl; R 2 represents the hydroxyl function of the carboxyl acid of C-terminal amino acid, free or substituted by a protector group which can be selected from C 1 to C 30 alkyl, -NH 2 , -NHY and -NYY group with Y representing a C 1 to C 4 alkyl, for increasing the expression of Ubiad1 in skin, skin appendages or epidermal cells including keratinocytes for improving physiological functions of the skin, comprising contacting the skin, skin appendages or epidermal cells with a composition containing the peptide, wherein the peptide of formula (I) consists of the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2.
A compound of structural Formula I: or pharmaceutically acceptable salt thereof, wherein: R 1 is H or -C 1-4 alkyl; R 2 is H or -C 1-4 alkyl, R 3 is -C 1-8 alkyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; R A is a geminally di-substituted amino acid ester residue of formula (iv): R 5 and R 6 are each CH 3 and R 9 is -C 1-8 alkyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. R 1 is H or -C 1-4 alkyl; R 2 is H or -C 1-4 alkyl, R 3 is -C 1-8 alkyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; R A is a geminally di-substituted amino acid ester residue of formula (iv): R 5 and R 6 are each CH 3 and R 9 is -C 1-8 alkyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
A bolus for administration to a ruminant animal, wherein said bolus comprises: a core, wherein the core includes a methane inhibitor to be administrated to the ruminant animal mixed with a carrier; and a housing which covers at least a portion of the core; wherein, the bolus is configured to release the methane inhibitor through the housing over a predetermined period of time, wherein the methane inhibitor is a haloform, wherein the haloform is selected from the list of bromoform, chloroform, iodoform, and combinations thereof. a core, wherein the core includes a methane inhibitor to be administrated to the ruminant animal mixed with a carrier; and a housing which covers at least a portion of the core; wherein, the bolus is configured to release the methane inhibitor through the housing over a predetermined period of time, wherein the methane inhibitor is a haloform, wherein the haloform is selected from the list of bromoform, chloroform, iodoform, and combinations thereof.
A method for preparing 3-[ -7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H- -benzodiazepin-3-yl] propionic acid methyl ester of formula (D) characterized in that it comprises the step of reacting methyl -4-amino-5-[4-bromo-2-(pyridin-2-carbonyl)anilino]-5-oxo-pentanoate hydrobromide salt of formula (I-C) with a base, wherein the compound of formula (I-C) is prepared by means of reacting methyl -4-(benzyloxycarbonylamino)-5-[4-bromo-2-(pyridin-2-carbonyl)anilino]-5-oxo-pentanoate (I-B) with hydrobromic acid.
An apparatus comprising: - a co-extrusion device for extruding a multi-layer structure having at least one primary layer and at least one secondary layer , so that the multi-layer structure leaves the co-extrusion device along an exit direction (X); - a mould provided with a pair of elements , at least one of said elements being movable towards the other in a moulding direction (Y), so as to compression mould an object from a multi-layer dose which was severed from the multi-layer structure; - a transport device for carrying the dose towards the mould , the transport device comprising at least one transport element which is movable along a path directed from a collecting position (Q1), in which the dose is collected by the transport element , towards a release position (Q2), in which the dose is released into the mould by the transport element ; characterized in that the apparatus further comprises means for modifying orientation of the dose while the dose is being transported by the transport device , so that the dose is introduced into the mould with an orientation in which the secondary layer extends transversely to the moulding direction (Y). - a co-extrusion device for extruding a multi-layer structure having at least one primary layer and at least one secondary layer , so that the multi-layer structure leaves the co-extrusion device along an exit direction (X); - a mould provided with a pair of elements , at least one of said elements being movable towards the other in a moulding direction (Y), so as to compression mould an object from a multi-layer dose which was severed from the multi-layer structure; - a transport device for carrying the dose towards the mould , the transport device comprising at least one transport element which is movable along a path directed from a collecting position (Q1), in which the dose is collected by the transport element , towards a release position (Q2), in which the dose is released into the mould by the transport element ;